Galecto Stock Net Income
| GLTO Stock | USD 25.76 3.82 12.91% |
As of the 23rd of January, Galecto retains the Market Risk Adjusted Performance of 0.5753, downside deviation of 8.67, and Risk Adjusted Performance of 0.1023. Galecto technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Galecto's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Galecto's valuation are provided below:We have found one hundred twenty available fundamental trends for Galecto, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to confirm Galecto's regular fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 23rd of January 2026, Market Cap is likely to drop to about 5.9 M. In addition to that, Enterprise Value is likely to grow to about (9.5 M) This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -19.3 M | -20.3 M | |
| Net Loss | -55.5 M | -58.2 M | |
| Net Loss | -19.3 M | -20.3 M | |
| Net Loss | (21.31) | (22.37) | |
| Net Income Per E B T | 1.15 | 1.13 |
Galecto | Net Income | Build AI portfolio with Galecto Stock |
Latest Galecto's Net Income Growth Pattern
Below is the plot of the Net Income of Galecto over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Galecto financial statement analysis. It represents the amount of money remaining after all of Galecto operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Galecto's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Galecto's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (21.44 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Galecto Net Income Regression Statistics
| Arithmetic Mean | (25,223,350) | |
| Coefficient Of Variation | (57.19) | |
| Mean Deviation | 11,631,206 | |
| Median | (15,869,000) | |
| Standard Deviation | 14,424,956 | |
| Sample Variance | 208.1T | |
| Range | 45.8M | |
| R-Value | (0.48) | |
| Mean Square Error | 171.4T | |
| R-Squared | 0.23 | |
| Significance | 0.05 | |
| Slope | (1,362,955) | |
| Total Sum of Squares | 3329.3T |
Galecto Net Income History
Other Fundumenentals of Galecto
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Galecto Net Income component correlations
Galecto Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Galecto is extremely important. It helps to project a fair market value of Galecto Stock properly, considering its historical fundamentals such as Net Income. Since Galecto's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Galecto's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Galecto's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galecto. If investors know Galecto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galecto listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galecto's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Galecto 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Galecto's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Galecto.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Galecto on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Galecto or generate 0.0% return on investment in Galecto over 90 days. Galecto is related to or competes with Transcode Therapeutics, Phio Pharmaceuticals, Aprea Therapeutics, Kiora Pharmaceuticals, In8bio, Acurx Pharmaceuticals, and Aptevo Therapeutics. Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflamm... More
Galecto Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Galecto's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Galecto upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.67 | |||
| Information Ratio | 0.122 | |||
| Maximum Drawdown | 273.14 | |||
| Value At Risk | (14.66) | |||
| Potential Upside | 17.97 |
Galecto Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Galecto's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Galecto's standard deviation. In reality, there are many statistical measures that can use Galecto historical prices to predict the future Galecto's volatility.| Risk Adjusted Performance | 0.1023 | |||
| Jensen Alpha | 3.33 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.4502 | |||
| Treynor Ratio | 0.5653 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Galecto's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Galecto January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1023 | |||
| Market Risk Adjusted Performance | 0.5753 | |||
| Mean Deviation | 11.25 | |||
| Semi Deviation | 7.18 | |||
| Downside Deviation | 8.67 | |||
| Coefficient Of Variation | 798.09 | |||
| Standard Deviation | 31.97 | |||
| Variance | 1021.88 | |||
| Information Ratio | 0.122 | |||
| Jensen Alpha | 3.33 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.4502 | |||
| Treynor Ratio | 0.5653 | |||
| Maximum Drawdown | 273.14 | |||
| Value At Risk | (14.66) | |||
| Potential Upside | 17.97 | |||
| Downside Variance | 75.11 | |||
| Semi Variance | 51.51 | |||
| Expected Short fall | (14.81) | |||
| Skewness | 7.08 | |||
| Kurtosis | 54.62 |
Galecto Backtested Returns
Galecto is unstable given 3 months investment horizon. Galecto holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 4.52% are justified by taking the suggested risk. Use Galecto Market Risk Adjusted Performance of 0.5753, downside deviation of 8.67, and Risk Adjusted Performance of 0.1023 to evaluate company specific risk that cannot be diversified away. Galecto holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 7.07, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Galecto will likely underperform. Use Galecto downside variance, and the relationship between the sortino ratio and accumulation distribution , to analyze future returns on Galecto.
Auto-correlation | -0.22 |
Weak reverse predictability
Galecto has weak reverse predictability. Overlapping area represents the amount of predictability between Galecto time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Galecto price movement. The serial correlation of -0.22 indicates that over 22.0% of current Galecto price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.22 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 14.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Galecto Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Galecto reported net income of (21.44 Million). This is 106.28% lower than that of the Biotechnology sector and 130.61% lower than that of the Health Care industry. The net income for all United States stocks is 103.75% higher than that of the company.
Galecto Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galecto's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galecto could also be used in its relative valuation, which is a method of valuing Galecto by comparing valuation metrics of similar companies.Galecto is currently under evaluation in net income category among its peers.
Galecto ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Galecto's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Galecto's managers, analysts, and investors.Environmental | Governance | Social |
Galecto Institutional Holders
Institutional Holdings refers to the ownership stake in Galecto that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Galecto's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Galecto's value.| Shares | Jpmorgan Chase & Co | 2025-03-31 | 0.0 | Squarepoint Ops Llc | 2025-06-30 | 0.0 | Novo A/s | 2025-06-30 | 99.9 K | Renaissance Technologies Corp | 2025-06-30 | 14.5 K | Susquehanna International Group, Llp | 2025-06-30 | 13.6 K | Ubs Group Ag | 2025-06-30 | 2.3 K | Bank Of America Corp | 2025-06-30 | 1.2 K | Tower Research Capital Llc | 2025-06-30 | 942 | Blackrock Inc | 2025-06-30 | 100.0 | Barclays Plc | 2025-06-30 | 100.0 | Sbi Securities Co Ltd | 2025-06-30 | 18.0 |
Galecto Fundamentals
| Return On Equity | -1.09 | ||||
| Return On Asset | -0.44 | ||||
| Current Valuation | 40.81 M | ||||
| Shares Outstanding | 1.59 M | ||||
| Shares Owned By Insiders | 3.56 % | ||||
| Shares Owned By Institutions | 13.38 % | ||||
| Number Of Shares Shorted | 172.44 K | ||||
| Price To Book | 7.05 X | ||||
| EBITDA | (21.11 M) | ||||
| Net Income | (21.44 M) | ||||
| Cash And Equivalents | 79.03 M | ||||
| Cash Per Share | 3.11 X | ||||
| Total Debt | 73 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 10.98 X | ||||
| Book Value Per Share | 5.02 X | ||||
| Cash Flow From Operations | (18.62 M) | ||||
| Short Ratio | 0.12 X | ||||
| Earnings Per Share | (12.11) X | ||||
| Price To Earnings To Growth | (0.01) X | ||||
| Target Price | 32.0 | ||||
| Beta | 1.41 | ||||
| Market Capitalization | 43.73 M | ||||
| Total Asset | 17.13 M | ||||
| Retained Earnings | (277.52 M) | ||||
| Working Capital | 15.64 M | ||||
| Net Asset | 17.13 M |
About Galecto Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galecto's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galecto using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galecto based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Galecto
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Galecto position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will appreciate offsetting losses from the drop in the long position's value.Moving together with Galecto Stock
Moving against Galecto Stock
| 0.84 | ZLAB | Zai Lab | PairCorr |
| 0.8 | KRRO | Frequency Therapeutics | PairCorr |
| 0.78 | LEGN | Legend Biotech Corp Downward Rally | PairCorr |
| 0.7 | SGMO | Sangamo Therapeutics | PairCorr |
| 0.68 | AAPG | Ascentage Pharma Symbol Change | PairCorr |
The ability to find closely correlated positions to Galecto could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Galecto when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Galecto - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Galecto to buy it.
The correlation of Galecto is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Galecto moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Galecto moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Galecto can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Galecto Piotroski F Score and Galecto Altman Z Score analysis. To learn how to invest in Galecto Stock, please use our How to Invest in Galecto guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galecto. If investors know Galecto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galecto listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galecto's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.